SCHEMBL9890187

SCHEMBL9890187

c1ccc2c(c1)c1cccnc1n2-c1ccc2oc3c(ccc4c5cc(-n6c7ccccc7c7cccnc76)ccc5oc43)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.37
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
FEN1 P39748 1/20 0.34
TSHR P16473 4/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
LMNA P02545 3/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
HTT P42858 2/20 0.33
KMT2A Q03164 2/20 0.33
USP2 O75604 1/20 0.33
RAB9A P51151 1/20 0.33
LIMK1 P53667 1/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30863907 0.93 NPC1 (0.40) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL15730368 0.93 NPC1 (0.40) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL9890440 0.93 MAPT (0.35) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL15730370 0.92 NPC1 (0.40) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL23439035 0.91 MAPT (0.45) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL9890129 0.91 MAPT (0.39) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL9890195 0.90 NCOA1 (0.38) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL5028008 0.90 MAPT (0.33) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL15730366 0.90 NPC1 (0.38) NCOA1MAPTNPC1FEN1TSHR
SCHEMBL15730367 0.90 NPC1 (0.38) NCOA1MAPTNPC1FEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 NCOA1 1720/4885MAPT 1303/4885NPC1 2467/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 NCOA1 1720/4885MAPT 1303/4885NPC1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.